Ontology highlight
ABSTRACT: Background
This study evaluated the cost-effectiveness of combination chemotherapy, radiotherapy, and surgical intervention (CRS) vs definitive chemotherapy and radiotherapy (CR) in clinical stage IIIA non-small cell lung cancer (NSCLC) patients at academic and nonacademic centers.Methods
Patients with clinical stage IIIA NSCLC receiving CR or CRS from 1998 to 2010 were identified in the National Cancer Data Base. Propensity score matching on patient, tumor, and treatment characteristics was performed. Medicare allowable charges were used for treatment costs. The incremental cost-effectiveness ratio (ICER) was based on probabilistic 5-year survival and calculated as cost per life-year gained.Results
We identified 5,265 CR and CRS matched patient pairs. Surgical rese
SUBMITTER: Samson P
PROVIDER: S-EPMC4847712 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature